SynthesisFrontiers in immunology2023

Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials.

Chengxin Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.